Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Perioperative Anxiety in Neurosurgical Patients
NCT07801014Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Randomised, open-label trial of dexmedetomidine in anxiety disorder (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: State-Trait Anxiety Inventory-State. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT07801014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07801014.